Sun et al. demonstrated that elevated CENP-A expression can be used as a prognostic and predictive cancer biomarker, especially for taxane-based chemotherapy and possibly other treatments targeting cell division, using genomic, transcriptomic and patient information from databases [16]. The gene discussed is CENPA; the disease is cancer.